Exact Mass: 520.254
Exact Mass Matches: 520.254
Found 199 metabolites which its exact mass value is equals to given mass value 520.254
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
7,8-Dihydrovomifoliol 9-[apiosyl-(1->6)-glucoside]
7,8-Dihydrovomifoliol 9-[apiosyl-(1->6)-glucoside] is found in fruits. 7,8-Dihydrovomifoliol 9-[apiosyl-(1->6)-glucoside] is a constituent of quince (Cydonia vulgaris) leaves
3b,6a-Dihydroxy-alpha-ionol 9-[apiosyl-(1->6)-glucoside]
3b,6a-Dihydroxy-alpha-ionol 9-[apiosyl-(1->6)-glucoside] is found in fruits. 3b,6a-Dihydroxy-alpha-ionol 9-[apiosyl-(1->6)-glucoside] is a constituent of Cydonia vulgaris (quince). Constituent of Cydonia vulgaris (quince). 3b,6a-Dihydroxy-alpha-ionol 9-[apiosyl-(1->6)-glucoside] is found in fruits.
(6R,9R)-9-Hydroxy-4-megastigmen-3-one 9-O-??-D-glucopyranosyl-(1鈥樏傗垎6)-??-D-glucopyranoside
(1R,2R,3R,4R,5S,7R,9S,10R)-1-benzoyloxy-9-cinnamoyloxy-2,3-dihydroxydihydro-beta-agarofuran
1beta-benzoyl-8alpha-cinnamoyl-4alpha,5alpha-dihydroxydihydroagarofuran
3alpha,6alpha-dihydroxymegastigman-7-en-9-one 3-O-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside|3alpha,6alpha-dihydroxymegastigman-7-en-9-one-3-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside
2-(2,4,5-Trihydroxyphenyl)-3,6,8-tris(3-methyl-2-butenyl)-5-hydroxy-7-methoxy-4H-1-benzopyran-4-one
3-hydroxy-5,6-epoxy-beta-ionol-3-O-beta-apiofuranosyl-(1->6)-beta-glucopyranoside
5R,6S,7E-megastigma-3-on-7-en-9-ol 9-O-beta-D-(6-O-beta-D-xylopyranosyl)glucopyranoside|ampelopsisionoside 6-O-beta-D-xylopyranoside|platanionoside C
5,7-Dihydroxy-6-methyl-2-phenyl-8-[1-(2-hydroxy-3,3,5,5-tetramethyl-4,6-dioxo-1-cyclohexenyl)-3-methylbutyl]-2H-1-benzopyran-4(3H)-one
13-hydroxyblumenol C apiosylglucoside|4-[3-(2-O-beta-apiofuranosyl-beta-glucopyranosyloxy)-butyl]-3-(hydroxymethyl)-5,5-dimethyl-2-cyclohexen-1-one
1-(3-Methoxy-4-hydroxyphenyl)-1-methoxy-2,3-bis(2-methoxy-4-allylphenoxy)propane
1b-Benzoyl-8a-cinnamoyl-4a,5a-dihydroxydihydroagarofuran
C24H40O12_(2R,3E)-4-[(1S,6R)-1-Hydroxy-2,2,6-trimethyl-4-oxocyclohexyl]-3-buten-2-yl 6-O-beta-D-xylopyranosyl-beta-D-glucopyranoside
Cys Arg Arg Ser
Cys Arg Ser Arg
Cys Ser Arg Arg
Glu Ile Pro Tyr
Glu Ile Tyr Pro
Glu Leu Pro Tyr
Glu Leu Tyr Pro
Glu Pro Ile Tyr
Glu Pro Leu Tyr
Glu Pro Tyr Ile
Glu Pro Tyr Leu
Glu Tyr Ile Pro
Glu Tyr Leu Pro
Glu Tyr Pro Ile
Glu Tyr Pro Leu
Gly Lys Met Trp
Gly Lys Trp Met
Gly Met Lys Trp
Gly Met Trp Lys
Gly Trp Lys Met
Gly Trp Met Lys
Ile Glu Pro Tyr
Ile Glu Tyr Pro
Ile Pro Glu Tyr
Ile Pro Tyr Glu
Ile Tyr Glu Pro
Ile Tyr Pro Glu
Lys Gly Met Trp
Lys Gly Trp Met
Lys Met Gly Trp
Lys Met Trp Gly
Lys Trp Gly Met
Lys Trp Met Gly
Leu Glu Pro Tyr
Leu Glu Tyr Pro
Leu Pro Glu Tyr
Leu Pro Tyr Glu
Leu Tyr Glu Pro
Leu Tyr Pro Glu
Met Gly Lys Trp
Met Gly Trp Lys
Met Lys Gly Trp
Met Lys Trp Gly
Met Trp Gly Lys
Met Trp Lys Gly
Pro Glu Ile Tyr
Pro Glu Leu Tyr
Pro Glu Tyr Ile
Pro Glu Tyr Leu
Pro Ile Glu Tyr
Pro Ile Tyr Glu
Pro Leu Glu Tyr
Pro Leu Tyr Glu
Pro Tyr Glu Ile
Pro Tyr Glu Leu
Pro Tyr Ile Glu
Pro Tyr Leu Glu
Arg Cys Arg Ser
Arg Cys Ser Arg
Arg Arg Cys Ser
Arg Arg Ser Cys
Arg Ser Cys Arg
Arg Ser Arg Cys
Ser Cys Arg Arg
Ser Arg Cys Arg
Ser Arg Arg Cys
Trp Gly Lys Met
Trp Gly Met Lys
Trp Lys Gly Met
Trp Lys Met Gly
Trp Met Gly Lys
Trp Met Lys Gly
Tyr Glu Ile Pro
Tyr Glu Leu Pro
Tyr Glu Pro Ile
Tyr Glu Pro Leu
Tyr Ile Glu Pro
Tyr Ile Pro Glu
Tyr Leu Glu Pro
Tyr Leu Pro Glu
Tyr Pro Glu Ile
Tyr Pro Glu Leu
Tyr Pro Ile Glu
Tyr Pro Leu Glu
25-Hydroxyvitamin D3-bromoacetate
7,8-Dihydrovomifoliol 9-[apiosyl-(1->6)-glucoside]
3b,6a-Dihydroxy-alpha-ionol 9-[apiosyl-(1->6)-glucoside]
25-Hydroxyvitamin D3-bromoacetate
(4Z,7Z,9E,11E,13R,14S,16Z,19Z)-13-[(2R)-2-amino-3-(carboxymethylamino)-3-oxopropyl]sulfanyl-14-hydroxydocosa-4,7,9,11,16,19-hexaenoic acid
5-(2-amino-1-hydroxyethyl)-2-[[(2R,3R,4S,5R,6R)-5-carbamoyloxy-3-(3,6-diaminohexanoylamino)-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]amino]-4,5-dihydro-1H-imidazole-4-carboxylic acid
(2-Methyl-4-(5-methyl-1,2,4-oxadiazol-3-yl)-[1,1-biphenyl]-4-yl)(1-methyl-6,7-dihydrospiro[furo[2,3-f]indole-3,4-piperidin]-5(2H)-yl)methanone
S-[(3Z,6R,7S,15Z,18Z)-21-carboxy-6-hydroxyhenicosa-3,8,10,12,15,18-hexaen-7-yl]-L-cysteinylglycine
3-[(3aS,10bS)-2-[4-(3-hydroxypropoxy)phenyl]-4-oxo-5-prop-2-enyl-6,10b-dihydrooxazolo[4,5-d][2]benzazepin-3a-yl]propanoic acid tert-butyl ester
N-[[(4R,5R)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[[(4R,5S)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[[(4R,5S)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[[(4S,5R)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[[(4S,5S)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[[(4S,5S)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[[(4R,5R)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[[(4S,5R)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-oxanecarboxamide
methyl 6-{[4,6-dideoxy-3-O-(4,6-dideoxy-4-formamido-2,3-di-O-methyl-alpha-D-mannopyranosyl)-4-formamido-alpha-D-mannopyranosyl]oxy}hexanoate
(4S,5S)-5-[(1R)-2-amino-1-hydroxyethyl]-2-[[(2R,3R,4S,5R,6R)-5-carbamoyloxy-3-[[(3S)-3,6-diaminohexanoyl]amino]-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]amino]-4,5-dihydro-1H-imidazole-4-carboxylic acid
(1Z,4S,12R,14S,17Z)-12-hydroxy-19,19-dimethyl-7-(3-methylbut-2-enyl)-3,5,16,21-tetrazaheptacyclo[14.13.0.03,14.04,12.06,11.020,28.022,27]nonacosa-1(29),6,8,10,17,20(28),22,24,26-nonaene-2,15-dione
(1Z,4R,5S,14S,16S,19Z)-14-hydroxy-5,6,6,21,21-pentamethyl-3,7,18,23-tetrazaoctacyclo[16.13.0.03,16.04,7.04,14.08,13.022,30.024,29]hentriaconta-1(31),8,10,12,19,22(30),24,26,28-nonaene-2,17-dione
(13R)-S-cysteinylglycinyl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid
A docosanoid that is (14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid in which a cysteinylglycinyl group is attached at position 13R via a sulfide linkage.
16(S)-glycinylcystein-S-yl-17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid
A docosanoid that is 17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid in which a cysteinylglycinyl group is attached at position 16S via a sulfide linkage. An intermediate of specialized proresolving mediators
SB 224289
A member of the class of benzamides obtained by formal condensation of the carboxy group of 2-methyl-4-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-carboxylic acid with the secondary amino group of 1-methyl-6,7-dihydro-5H-spiro[furo[2,3-f]indole-3,4-piperidine]. Selective 5-HT1B receptor antagonist (pKi = 8.2). Displays >60-fold selectivity over 5-HT1D, 5-HT1A, 5-HT1E, 5-HT1F, 5-HT2A and 5-HT2C receptors in radioligand binding and functional assays. Centrally active following oral administration in vivo.
5-(acetyloxy)-12-(benzoyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate
(1s,2r,5s,6s,7r,9r,12s)-7-(acetyloxy)-5-(benzoyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-12-yl benzoate
(1s,2r,3r,4r,5r,6r,7s,9r)-3,4-dihydroxy-2,6,10,10-tetramethyl-7-{[(2e)-3-phenylprop-2-enoyl]oxy}-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl benzoate
(4s)-5,5-dimethyl-4-[(3r)-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}butyl]cyclohex-2-en-1-one
3,4-dihydroxy-2,6,10,10-tetramethyl-7-[(3-phenylprop-2-enoyl)oxy]-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl benzoate
4-(4-{[6-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-1-hydroxy-2,2,6-trimethylcyclohexyl)but-3-en-2-one
(1z,4s,12r,14r,17z)-12-hydroxy-19,19-dimethyl-5-(3-methylbut-2-en-1-yl)-3,5,16,21-tetraazaheptacyclo[14.13.0.0³,¹⁴.0⁴,¹².0⁶,¹¹.0²⁰,²⁸.0²²,²⁷]nonacosa-1(29),6,8,10,17,20(28),22,24,26-nonaene-2,15-dione
2-(2,6-dihydroxy-4-methoxyphenyl)-5,7-dihydroxy-8-[5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-6-(3-methylbut-2-en-1-yl)chromen-4-one
(6r,9r)-9-hydroxy-4-megastigmen-3-one 9-o-β-d-glucopyranosyl-(1→6)-β-d-glucopyrano-side
{"Ingredient_id": "HBIN012787","Ingredient_name": "(6r,9r)-9-hydroxy-4-megastigmen-3-one 9-o-\u03b2-d-glucopyranosyl-(1\u21926)-\u03b2-d-glucopyrano-side","Alias": "NA","Ingredient_formula": "C24H40O12","Ingredient_Smile": "CC(CCC1C=CC(=O)CC1(C)C)OC2C(C(C(C(O2)COC3C(C(C(C(O3)CO)O)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10373","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}